Diabetes care devices market which is USD 29.02 billion in 2022, is expected to reach USD 56.57 billion by 2030, at a CAGR of 8.7% during the forecast period 2023 to 2030. The key factor that drives the Diabetes Care Devices Market Growth includes an increase in the incidence of diabetes and a change in urbanization & sedentary lifestyle. In addition, technological advancements in the field of diabetes devices, a rise in the diabetic population across the globe, a surge in the need for fast & safe diagnosis, and a rise in treatments for diabetes dominate the diabetic care market during the forecast period.However, blood glucose monitoring devices do not measure the exact level of glucose in the blood but give a range of blood glucose levels. In addition, adverse effects associated with some of the diabetes care devices hinder the market growth. A rise in awareness about diabetes monitoring devices and untapped market opportunities in developing regions are expected to provide Diabetes Care Devices Market Opportunity.

Get the sample copy of Report here:


Diabetes Care Devices Market report is a window to the healthcare industry which gives explanation about what market definition, classifications, applications, engagements and market trends are. It also gives details regarding the actions of major players such as product launches, joint ventures, developments, mergers and acquisitions and respective effects in terms of sales, import, export, revenue and CAGR values for the Healthcare industry. This industry analysis report is a significant document for every market enthusiast, policymaker, investor, and market player. Diabetes Care Devices Market document is a great source of getting information for the major happenings and industry insights which helps succeed in this competitive age.

Product Type

  • Blood Glucose Monitoring Devices
  • Testing Strips
  • Blood Glucose Meters
  • Self-monitoring Blood Glucose Meters
  • Continuous Blood Glucose Monitoring Devices
  • Lancets
  • Others
  • Insulin Delivery Devices

Device Type

  • Self-monitoring
  • Diagnostic

Delivery Type

  • Pumps
  • Pen
  • Syringes
  • Injectors
  • Cartridges in Reusable pens
  • Disposable Pens
  • Jet Injectors

 Distribution Channel

  • Institutional Sales
  • Hospitals
  • Clinics
  • Others
  • Retail Sales
  • Hospital pharmacies
  •  Retail pharmacies
  • Online pharmacies

The global diabetes care devices market can be segmented based on product type and end-use outlook.In terms of product type, the market can be divided into insulin pumps, self-monitoring blood glucose (SMBG) devices, continuous glucose monitoring (CGM) systems, lancets, and other devices. Insulin pumps are expected to witness significant growth due to their benefits, such as precise insulin dosing, improved glucose control, and reduced risk of hypoglycemia. Self-monitoring blood glucose (SMBG) devices are also expected to register significant growth, owing to the increasing adoption of self-monitoring devices and rising need for accurate and real-time monitoring of blood glucose levels in diabetic patients. The demand for CGM devices is rapidly increasing, primarily driven by the rising need for accurate and real-time monitoring of blood glucose levels in diabetic patients. Lancets and other devices are also expected to contribute to the growth of the market.


Get Full Access of Report


Highlight of Table of Content:

·        Chapter 1: Market overview

·        Chapter 2: Global Diabetes Care Devices Market analysis

·        Chapter 3: Regional analysis of the Global Diabetes Care Devices Market

·        Chapter 4: Market segmentation based on types and applications

·        Chapter 5: Revenue analysis based on types and applications

·        Chapter 6: Market share

·        Chapter 7: Competitive Landscape

·        Chapter 8: Drivers, Restraints, Challenges, and Opportunities

·        Chapter 9: Gross Margin and analysis

Some of the major players operating in the diabetes care devices market are:

  • Abbott (U.S.)
  • PHC Holdings Corporation (Japan)
  • WellDoc, Inc (India)
  • Sanofi (France)
  • Dexcom, Inc (U.S.)
  • DarioHealth Corp. (U.S.)
  • Medtronic (Ireland)
  • B. Braun SE (Germany)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Insulet Corporation (U.S.)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • Tidepool (U.S.)
  • Medtronic (Ireland)
  • Tandem Diabetes Care (U.S.)
  • LifeScan (U.S.)
  • AgaMatrix (U.S.)
  • Glooko Inc. (U.S.)


Get TOC Details:



Related Reports

 lymphangioleiomyomatosis Treatment Market   

 Primary sclerosing cholangitis Market



About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market


Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com